Magenta Therapeutics, Inc.
MGTA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$36,765 | -$31,629 | -$29,511 | -$32,337 |
| Dep. & Amort. | $99 | $99 | $133 | -$475 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5,794 | $5,706 | $5,315 | $10,208 |
| Change in WC | $0 | $0 | $0 | $18,973 |
| Other Non-Cash | $317 | $1,932 | -$3,567 | -$15,718 |
| Operating Cash Flow | -$30,555 | -$23,892 | -$27,630 | -$19,349 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$5 | -$46 | -$24 | $296 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$279,841 | -$33,113 | -$67,324 | -$394,160 |
| Inv. Sales/Matur. | $78,571 | $59,604 | $82,142 | $52,000 |
| Other Inv. Act. | $0 | $0 | $0 | -$5,538 |
| Investing Cash Flow | -$201,275 | $26,445 | $14,794 | -$347,402 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $187 | $0 | $129 | $36,296 |
| Stock Repurch. | $0 | $0 | $0 | -$49,819 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $274,513 | $568 | $161 | $205,853 |
| Financing Cash Flow | $274,513 | $568 | $161 | $205,853 |
| Forex Effect | $0 | $0 | $0 | $12,330 |
| Net Chg. in Cash | $42,683 | $3,121 | -$12,675 | -$39,611 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $13,468 | $10,347 | $23,022 | $62,633 |
| End Cash | $56,151 | $13,468 | $10,347 | $23,022 |
| Free Cash Flow | -$30,560 | -$23,938 | -$27,654 | -$19,053 |